Company Filing History:
Years Active: 2005-2006
Title: Eric Bacqué: Innovator in Oncology
Introduction
Eric Bacqué is a notable inventor based in Gif sur Yvette, France. He has made significant contributions to the field of human medicine, particularly in oncology. With a total of 4 patents to his name, Bacqué's work focuses on developing novel compounds that can aid in the treatment of tumors and cancerous cells.
Latest Patents
Among his latest patents, Bacqué has developed indazole or indole derivatives, which are crucial in the fight against cancer. These compounds are designed to treat tumors or cancerous cells effectively. His invention includes pharmaceutical compositions that comprise a pharmaceutically acceptable carrier along with these innovative compounds. Another significant patent involves heterocyclylalkylpiperidine derivatives, which are presented in various forms, including their enantiomeric or diastereoisomeric forms. This patent also covers the preparation of these derivatives and the compositions that contain them.
Career Highlights
Eric Bacqué is associated with Aventis Pharma S.A., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapeutic options for patients suffering from cancer. His innovative approach and dedication to research have made him a respected figure in the pharmaceutical industry.
Collaborations
Throughout his career, Bacqué has collaborated with esteemed colleagues such as Michel Tabart and Jean-Luc Malleron. These partnerships have fostered an environment of innovation and have contributed to the advancement of medical research.
Conclusion
Eric Bacqué's contributions to oncology through his patents and collaborations highlight his commitment to improving human health. His innovative work continues to pave the way for new treatments in the fight against cancer.